(S)-(4-(3-chloro-4-methoxybenzylamino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone

ID: ALA3404016

Chembl Id: CHEMBL3404016

PubChem CID: 118730141

Max Phase: Preclinical

Molecular Formula: C27H31ClN4O6

Molecular Weight: 543.02

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)c2cc(OC)c(OC)c(OC)c2)cc1Cl

Standard InChI:  InChI=1S/C27H31ClN4O6/c1-35-21-8-7-16(10-20(21)28)13-29-26-19(14-30-27(31-26)32-9-5-6-18(32)15-33)24(34)17-11-22(36-2)25(38-4)23(12-17)37-3/h7-8,10-12,14,18,33H,5-6,9,13,15H2,1-4H3,(H,29,30,31)/t18-/m0/s1

Standard InChI Key:  DCPRQVBIYYJVHB-SFHVURJKSA-N

Alternative Forms

  1. Parent:

    ALA3404016

    ---

Associated Targets(non-human)

PDE5A Phosphodiesterase 5A (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corpus cavernosum (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 543.02Molecular Weight (Monoisotopic): 542.1932AlogP: 3.97#Rotatable Bonds: 11
Polar Surface Area: 115.27Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.68CX LogP: 4.49CX LogD: 4.48
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -0.68

References

1. Sakamoto T, Koga Y, Hikota M, Matsuki K, Mochida H, Kikkawa K, Fujishige K, Kotera J, Omori K, Morimoto H, Yamada K..  (2015)  8-(3-chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors.,  25  (7): [PMID:25754491] [10.1016/j.bmcl.2015.02.041]

Source